BIOTECanada provided feedback to Innovation Science and Economic Development to inform the design of the life sciences stream of the Venture Capital Catalyst Initiative (VCCI).
As the national biotechnology association representing the broader Canadian biotech ecosystem, the Industry strongly endorses the creation of the $200M Life Sciences Venture Capital Catalyst Initiative (LS-VCCI) and encourages its rapid deployment. Additionally, BIOTECanada encourages that this program be renewable on a cycle commensurate with other VCCI programs to catalyze the expansion of Canada’s domestic venture capital supply such that Canada’s nationally funded innovation capacity can be maximized.